Andrea Weiss
Geneve, GE 1211, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance.
Journal: Cancers
Published: September 11, 2020
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment.
Journal: Cancers
Published: July 28, 2020
Identification of low-dose multidrug combinations for sunitinib-naive and pre-treated renal cell carcinoma.
Journal: British journal of cancer
Published: December 01, 2019
The role of glycolysis and mitochondrial respiration in the formation and functioning of endothelial tip cells during angiogenesis.
Journal: Scientific reports
Published: April 04, 2019
Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression.
Journal: British journal of cancer
Published: March 11, 2019
Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug.
Journal: ChemMedChem
Published: February 20, 2018
Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.
Journal: Angiogenesis
Published: February 05, 2017
Current Trends in Multidrug Optimization.
Journal: Journal of laboratory automation
Published: January 18, 2017
Current Trends in Multidrug Optimization: An Alley of Future Successful Treatment of Complex Disorders.
Journal: SLAS technology
Published: December 28, 2016
Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity.
Journal: Scientific reports
Published: July 12, 2016
Last Updated: 09/26/2026